Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mydecine Innovations Group Inc
(OP:
MYCOF
)
0.0075
+0.0020 (+36.36%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Mydecine Innovations Group Inc
< Previous
1
2
3
4
Next >
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Excited for Seamless Phase 2/3 Clinical Research as Dr. Matthew Johnson Presents Interim Results of Current Smoking Cessation Study at the Psychedelic Medicine Business Event: Wonderland
November 22, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) CEO Discusses Blockbuster Drug Potential on MidasLetter Podcast
November 18, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Featured in ROTH Equity Research Report
November 17, 2021
Via
Investor Brand Network
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Files Technology Patent Application Covering Bioavailability-Enhancing, Nanoemulsion-Empowered Formulations
November 15, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
BioMedNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) CMO to Participate in Horizons’ Veterans & Families Forum
November 10, 2021
Via
Investor Brand Network
Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Validates its AI-Driven Drug Discovery Program with Successful Synthesis of Novel Tryptamine; Confirms Participation in the Wonderland: Miami Psychedelic Medicine Business Event
November 05, 2021
Via
Investor Brand Network
NetworkNewsAudio – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Offers Hope on the Smoking-Cessation Horizon
November 04, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Files Patent Covering Formulations Featuring Nanoemulsion
November 03, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Psychedelics Offer Hope for Mental Disorders, Addiction
November 03, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Why Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Is ‘One to Watch’
November 02, 2021
Via
Investor Brand Network
Breaking the Habit: Psychedelic Stigma Fades as Research Points to Critical Use in Smoking Cessation and More
November 01, 2021
Via
Investor Brand Network
InvestorNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Announces Participation in November Event
October 29, 2021
Via
Investor Brand Network
Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Is ‘One to Watch’
October 27, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Successfully Synthesizes Novel Psilocin Analogue
October 27, 2021
Via
Investor Brand Network
Psychedelics Called the ‘Next Frontier’ for Investors, Also Offer Promising Treatments
September 29, 2021
Via
Investor Brand Network
Rising Acceptance For Treating Mental Disorders is Fueling Strong Growth in Psychedelic Drugs Market
October 14, 2021
Palm Beach, FL –October 14, 2021 – FinancialNewsMedia.com News Commentary – Mental disorders are an urgent health crisis worldwide, especially exacerbated by COVID-19. As per a study by Harvard, the...
Via
FinancialNewsMedia
Exposures
COVID-19
National Suicide Prevention Week Shines Light on Psychedelic Treatments
September 09, 2021
Via
FinancialNewsMedia
Psychedelics Gain More Traction as New Research Aims to Address Chronic Pain and Mental Illness
July 21, 2021
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
Legal
Telehealth Boom Is Driving this Mental Health Company’s Progress
July 13, 2021
Via
FinancialNewsMedia
Mydecine Reports First Quarter 2021 Financial Results and Provides Business Update
May 20, 2021
Via
Get News
With Number Of Depression Cases Rising, Psilocybin Medicines Are Being Rapidly Accepted
April 22, 2021
Via
FinancialNewsMedia
Biotech Companies Driving Psychedelics Industry Forward with Key Research
April 13, 2021
Via
FinancialNewsMedia
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.